Building this habit eliminates the "I just set it down for a second" problem that leads to hours-long counter exposure
Consistent support from health care teams is key to long-term success
Using tools like the Health Quiz can help you move beyond general advice and find the specific combination of nutrients that fits your current life stage
A review of their potential efficacy and suitability
It has been established through clinical trials that GLP-1 receptor agonists (liraglutide and semaglutide) have proven to be consistently useful in lowering body weight, enhancing glycaemic control, and reducing cardiovascular risk [7,8,9].Nevertheless, since GLP-1 receptor agonists have the capability to work on several central nervous pathways, including the one controlling appetite, reward circuits, and the pancreatic-enteric-brain axis, the potential psychological impact of such agonists has increased with time [10,11,12]
For example, semaglutide 2.4mg (Wegovy) has demonstrated approximately 15% weight loss at 68 weeks in clinical trials, while liraglutide 3mg (Saxenda) typically achieves around 8% at 56 weeks